×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Equillium, Inc. (EQ) Reports Q1 Loss, Tops Revenue Estimates
Yahoo Finance
Equillium, Inc. (EQ) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.17.
1 day ago
Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights
Business Wire
Equillium Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel...
1 day ago
Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists
Business Wire
Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and...
3 days ago
Little Excitement Around Equillium, Inc.'s (NASDAQ:EQ) Revenues
Simply Wall St
With a price-to-sales (or "P/S") ratio of 2x Equillium, Inc. ( NASDAQ:EQ ) may be sending very bullish signals at the...
1 month ago
Equillium to advance EQ-302 in place of EQ-102 for gastrointestinal and skin diseases
BioWorld MedTech
Equillium Inc. has announced that it intends to advance EQ-302, a preclinical orally delivered multi-cytokine inhibitor of IL-15 and IL-21,...
4 months ago
Equillium, Inc. (EQ) Reports Q4 Loss, Tops Revenue Estimates
Yahoo Finance
Equillium (EQ) delivered earnings and revenue surprises of 58.82% and 4.08%, respectively, for the quarter ended December 2023.
1 month ago
SGIOY: 3 Biotech Stocks Making Major Moves on Wall Street
StockNews.com
Shionogi & Co., Ltd.(OTC:SGIOY): The biotechnology industry is experiencing significant growth, fueled by government initiatives, rising investments and...
2 months ago
Equillium reports promising lupus treatment results in study
Investing.com
LA JOLLA, Calif. - Equillium, Inc. (NASDAQ:EQ), a biotechnology firm, has announced positive preliminary data from a study evaluating...
1 month ago
We Think Equillium (NASDAQ:EQ) Needs To Drive Business Growth Carefully
Simply Wall Street
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price.
1 week ago
Equillium Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical Updates
Business Wire
Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel...
6 months ago